Sulopenem etzadroxil Uses, Dosage, Side Effects and more
Sulopenem etzadroxil is under investigation in clinical trial NCT03354598 (Oral Sulopenem-etzadroxil/probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women).
| Attribute | Details |
|---|---|
| Trade Name | Sulopenem etzadroxil |
| Generic | Sulopenem etzadroxil |
| Sulopenem etzadroxil Other Names | Sulopenem etzadroxil |
| Type | |
| Formula | C19H27NO7S3 |
| Weight | Average: 477.61 Monoisotopic: 477.094965735 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
